Nivolumab in disadvantaged subgroups of metastatic non-small-cell lung cancer patients: a single-institution experience

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Nivolumab in disadvantaged subgroups of metastatic non-small-cell lung cancer patients: a single-institution experience'. Together they form a unique fingerprint.

Medicine & Life Sciences